Pacific Biosciences of California Inc (NAS:PACB)
$ 1.645 -0.025 (-1.5%) Market Cap: 448.02 Mil Enterprise Value: 817.48 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 58/100

Q3 2021 Pacific Biosciences of California Inc Earnings Call Transcript

Nov 02, 2021 / 08:30PM GMT
Release Date Price: $27.95 (+0.98%)
Operator

Good day, everyone, and thank you for standing by. Welcome to the Pacific Biosciences of California, Inc. Third Quarter 2021 Earnings Conference Call. (Operator Instructions)

I would now like to hand the conference over to the Director of Investor Relations, Mr. Todd Friedman. Please go ahead, sir.

Todd Friedman
Pacific Biosciences of California, Inc. - Director of IR

Good afternoon, and welcome to PacBio's Third Quarter 2021 Earnings Conference Call. Earlier today, we issued a press release outlining the financial results we will be discussing on today's call, a copy of which is available on the Investors section of our website at www.pacb.com, or alternatively as furnished on Form 8-K available on the Securities and Exchange Commission website at www.sec.gov.

With me today are Christian Henry, President and Chief Executive Officer; Susan Kim, Chief Financial Officer; and Mark Van Oene, Chief Operating Officer.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot